Three new cases of COVID-19 were identified out of 1,147 tests performed on Tuesday, March 16. Two (2) cases reported recent travel history and were identified in quarantine. To date, there have been a total of 7,776 officially reported cases of COVID-19 with 134 deaths, 24 cases in active isolation, and 7,618 not in active isolation.
|
TODAY’S CAR SCORE |
0.2 |
The COVID Area Risk (CAR) Score accounts for the incidence of new cases, how well current testing identifies these cases, and the rate of spread. The ideal long-term goal is to sustain a CAR Score of 2.5 or less, which has been shown to correlate with very low to zero COVID-related hospitalizations and deaths.
The following tables provide COVID-19 test results reported to the JIC on Wednesday, March 17, and reflects results from Tuesday, March 15:
|
COVID-19 CASE COUNT |
TOTAL |
NEW CASES REPORTED TODAY |
PAST 7 DAYS |
|
COVID-19 CASES: |
7,776 |
3 |
20 |
|
CONFIRMED CASES: |
7,566 |
3 |
20 |
|
PROBABLE CASES: |
210 |
0 |
0 |
|
COVID-19 TESTING ON GUAM |
TOTAL |
NEW TESTS REPORTED TODAY |
7-DAY % POSITIVE |
|
DIAGNOSTIC TESTS |
135,075 |
1,147 |
1.2% |
|
MOLECULAR TESTS |
125,232 |
1,130 |
1.3% |
|
ANTIGEN TEST |
9,843 |
17 |
0% |
|
SEROLOGY TESTS |
360 |
0 |
50% |
|
CASE BREAKDOWN |
|||
|
STATUS |
TOTAL |
CURRENT ISOLATION LOCATION |
TOTAL |
|
COVID-19 Death |
134 |
Hospital |
4 |
|
Active Isolation |
24 |
Home |
7 |
|
Not In Isolation |
7,618 |
Isolation Facility |
6 |
|
Civilian |
7,380 |
Military |
7 |
|
Military Service Member |
396 |
|
COVID HOSPITAL CENSUS |
Guam Memorial Hospital |
Guam Regional Medical City |
U.S. Naval Hospital |
TOTAL |
|
COVID ADMISSION |
4 |
0 |
0 |
4 |
|
IN ICU |
0 |
0 |
0 |
0 |
|
ON VENTILATOR |
0 |
0 |
0 |
0 |
The following provides preliminary COVID-19 vaccinations reported to the JIC on Wednesday, March 17, for vaccinations administered from December 17 to March 16:
|
Vaccine Maker |
1st Doses Administered |
2nd Doses Administered |
Total Doses Administered |
Individuals Fully Immunized |
|
Pfizer-BioNTech |
18,786 |
15,656* |
34,442 |
15,656 |
|
Moderna |
16,196** |
14,134*** |
30,330 |
14,134 |
|
Johnson & Johnson Janssen |
– |
– |
11**** |
11**** |
|
TOTALS: |
34,993 |
29,790 |
64,783^ |
29,801 |
*Administering second doses of Pfizer-BioNTech COVID-19 vaccinations began on January 4, 2021.
**Administering first doses of Moderna COVID-19 vaccinations began on January 8, 2021.
***Administering second doses of Moderna COVID-19 vaccinations began on January 29, 2021.
****Johnson &Johnson/Janssen COVID-19 vaccinations began on March 15 and were developed as a one dose series.
|
Total Doses Administered |
Total Doses Allotted |
% Administered |
Doses Remaining |
|
64,783^ |
87,860^^ |
73.73% |
23,077 |
^As of March 16, 2021. Total doses administered and allotted doses differ as vaccinators were able to draw additional doses per vial. Additionally, the U.S. Food and Drug Administration’s February 25, 2021 revision of their Fact Sheet relative to the Pfizer-BioNTech Emergency Use Authorization now states “After dilution, one vial contains 6 doses of 0.3 mL. Vial labels and cartons may state that after dilution, a vial contains 5 doses of 0.3 mL. The information in this Fact Sheet regarding the number of doses per vial after dilution supersedes the number of doses stated on vial labels and cartons.” | ^^Reflects the previous allocation total of 86,560 and last received allocation of 1,300 Johnson & Johnson Janssen vaccines on March 8, 2021.
(JIC Release No. 605)
##
